Skip to main content

Butenafine topical Pregnancy and Breastfeeding Warnings

Medically reviewed by Last updated on Oct 3, 2022.

Butenafine topical is also known as: Lotrimin Ultra Athlete's Foot Cream, Lotrimin Ultra Jock Itch Cream, Mentax

Butenafine topical Pregnancy Warnings

Animal studies have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: C

See references

Butenafine topical Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

-This drug is not likely to reach the infant's bloodstream or to cause side effects in nursing infants due to poor absorption after topical administration.
-The infant's skin should not come into direct contact with skin that has been treated.
-Ointments should not be applied to the breast prior to breastfeeding; water miscible cream or gel products should be used if necessary.

See references

References for pregnancy information

  1. "Product Information. Mentax (butenafine topical)." Penederm Inc (2001):

References for breastfeeding information

  1. "Product Information. Mentax (butenafine topical)." Penederm Inc (2001):
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network." (2013):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.